These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 15683960)

  • 21. Alzheimer's disease and other neurological disorders.
    Henderson VW
    Climacteric; 2007 Oct; 10 Suppl 2():92-6. PubMed ID: 17882682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hormone replacement Up-to-date. Menopause in women and hormone replacement therapy (HRT). Indications for HRT in postmenopausal women].
    Ohta H
    Clin Calcium; 2007 Sep; 17(9):1315-24. PubMed ID: 17767019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E; Zyriax BC; Eidenmüller B; Boeing H
    Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogens and hormone replacement therapy: is there a role in the preservation of cognitive function?
    Bieber EJ; Cohen DP
    Int J Fertil Womens Med; 2001; 46(4):206-9. PubMed ID: 11563830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
    Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC;
    Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HRT and dementia.
    Skoog I; Gustafson D
    J Epidemiol Biostat; 1999; 4(3):227-51; discussion 252. PubMed ID: 10695961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormone replacement therapy and cognition in an Australian representative sample aged 60-64 years.
    Low LF; Anstey KJ; Jorm AF; Christensen H; Rodgers B
    Maturitas; 2006 Apr; 54(1):86-94. PubMed ID: 16226000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasoactive biomarkers and oxidative stress in healthy recently postmenopausal women treated with hormone replacement therapy.
    Maffei S; Mercuri A; Prontera C; Zucchelli GC; Vassalle C
    Climacteric; 2006 Dec; 9(6):452-8. PubMed ID: 17085378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
    Kuhl H; Stevenson J
    Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of postmenopausal hormone replacement therapy on body fat composition.
    Yüksel H; Odabasi AR; Demircan S; Köseoğlu K; Kizilkaya K; Onur E
    Gynecol Endocrinol; 2007 Feb; 23(2):99-104. PubMed ID: 17454160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Menopause and stroke and the effects of hormonal therapy.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.
    Harman SM; Naftolin F; Brinton EA; Judelson DR
    Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postmenopausal hormone therapy: new questions and the case for new clinical trials.
    Manson JE; Bassuk SS; Harman SM; Brinton EA; Cedars MI; Lobo R; Merriam GR; Miller VM; Naftolin F; Santoro N
    Menopause; 2006; 13(1):139-47. PubMed ID: 16607110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen: a neuroprotective or proinflammatory hormone? Emerging evidence from reproductive aging models.
    Sohrabji F
    Ann N Y Acad Sci; 2005 Jun; 1052():75-90. PubMed ID: 16024752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alzheimer's disease in women.
    Craig MC; Murphy DG
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):53-61. PubMed ID: 19028146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cardiovascular effects of estrogen in postmenopausal women].
    Zhu WL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Aug; 24(4):409-12. PubMed ID: 12905664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A women's health issue: Alzheimer's disease and strategies for maintaining cognitive health.
    Brinton RD
    Int J Fertil Womens Med; 1999; 44(4):174-85. PubMed ID: 10499738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognition and cognitive aging.
    Henderson VW
    Climacteric; 2007 Oct; 10 Suppl 2():88-91. PubMed ID: 17882681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. WHI and WHIMS follow-up and human studies of soy isoflavones on cognition.
    Zhao L; Brinton RD
    Expert Rev Neurother; 2007 Nov; 7(11):1549-64. PubMed ID: 17997703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease.
    Mohandas B; Mehta JL
    Curr Opin Cardiol; 2007 Sep; 22(5):434-42. PubMed ID: 17762545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.